Literature DB >> 21932935

Defining the phenotypes of sickle cell disease.

Samir K Ballas1.   

Abstract

The sickle cell gene is pleiotropic in nature. Although it is a single gene mutation, it has multiple phenotypic expressions that constitute the complications of sickle cell disease. The frequency and severity of these complications vary considerably both latitudinally in patients and longitudinally in the same patient over time. Thus, complications that occur in childhood may disappear, persist or get worse with age. Dactylitis and stroke, for example, occur mostly in childhood, whereas leg ulcers and renal failure typically occur in adults. It is essential that the phenotypic manifestations of sickle cell disease be defined accurately so that communication among providers and researchers facilitates the implementation of appropriate and cost-effective diagnostic and therapeutic modalities. The aim of this review is to define the complications that are specific to sickle cell disease based on available evidence in the literature and the experience of hematologists in this field.

Entities:  

Mesh:

Year:  2011        PMID: 21932935     DOI: 10.3109/03630269.2011.610477

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  6 in total

1.  Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia: A first report from Central Africa.

Authors:  Tite M Mikobi; Prosper Lukusa Tshilobo; Michel N Aloni; Pierre Z Akilimali; Georges Mvumbi-Lelo; Jean Marie Mbuyi-Muamba
Journal:  J Clin Lab Anal       Date:  2017-01-23       Impact factor: 2.352

2.  Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

Authors:  Yali Xue; Yuan Chen; Qasim Ayub; Ni Huang; Edward V Ball; Matthew Mort; Andrew D Phillips; Katy Shaw; Peter D Stenson; David N Cooper; Chris Tyler-Smith
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

3.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

4.  Interventions for treating neuropathic pain in people with sickle cell disease.

Authors:  Monika R Asnani; Damian K Francis; Amanda M Brandow; Christine Eo Hammond Gabbadon; Amza Ali
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

5.  Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq.

Authors:  Nasir Al-Allawi; Ameen M Mohammad; Shakir Jamal
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

6.  Provider Perspective on Integrative Medicine for Pediatric Sickle Cell Disease-related Pain.

Authors:  Caitlin M Neri; Tishra Beeson; Holly Mead; Deepika S Darbari; Emily Riehm Meier
Journal:  Glob Adv Health Med       Date:  2016-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.